Newly released Medicare national coverage determinations are set to reshape the home ventilation landscape for chronic ...

The following is a summary of “Triple overlap of COPD, severe obesity, and high risk of OSA: insights from an NHANES analysis ...

Global Ventilators Market is expected to witness a decent growth rate of 6-8% by 2026. Rising cases of respiratory diseases, chronic obstructive pulmonary disease (COPD), sleep apnea, acute lung ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

ResMed dominates an enormous, underdiagnosed market with recurring revenue and digital health leadership. Read why RMD stock ...

A new study to be presented at the SLEEP 2025 annual meeting found that sleep medicine professionals favor continuous ...

ResMed Inc. research and ratings by Barron's. View RMD revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

Objective: To investigate whether the presence of obstructive sleep apnea syndrome (OSAS) alters the perception of respiratory symptoms and quality of life in COPD patients, by using specific ...

Statistics show that obstructive sleep apnea (OSA) is a common disorder affecting around 30 million adults in the US. In a recent press release, the American Food and Drug Administration has ...

Introduction/Background: Chronic Obstructive Pulmonary Disease (COPD) is a major health issue characterized by long-term breathing problems and poor airflow, leading ...

and pulmonary edema. BiPAP is beneficial when there is mixed sleep apnea, meaning that there are components of both CSA and OSA. In certain cases of COVID-19, BiPAP can be used to delay mechanical ...